Suppression of HIV Replication by CD8(+) Regulatory T-Cells in Elite Controllers
Overview
Authors
Affiliations
We previously demonstrated in the Chinese macaque model that an oral vaccine made of inactivated SIV and Lactobacillus plantarum induced CD8(+) regulatory T-cells, which suppressed the activation of SIV(+)CD4(+) T-cells, prevented SIV replication, and protected macaques from SIV challenges. Here, we sought whether a similar population of CD8(+) T-regs would induce the suppression of HIV replication in elite controllers (ECs), a small population (3‰) of HIV-infected patients with undetectable HIV replication. For that purpose, we investigated the in vitro antiviral activity of fresh CD8(+) T-cells on HIV-infected CD4(+) T-cells taken from 10 ECs. The 10 ECs had a classical genomic profile: all of them carried the KIR3DL1 gene and 9 carried at least 1 allele of HLA-B:Bw4-80Ile (i.e., with an isoleucine residue at position 80). In the nine HLA-B:Bw4-80Ile-positive patients, we demonstrated a strong viral suppression by KIR3DL1-expressing CD8(+) T-cells that required cell-to-cell contact to switch off the activation signals in infected CD4(+) T-cells. KIR3DL1-expressing CD8(+) T-cells withdrawal and KIR3DL1 neutralization by a specific anti-killer cell immunoglobulin-like receptor (KIR) antibody inhibited the suppression of viral replication. Our findings provide the first evidence for an instrumental role of KIR-expressing CD8(+) regulatory T-cells in the natural control of HIV-1 infection.
Ahmed R, Adekoya K, Onwuamah C, Oboh B, Iyer S, Oluwatosin A Viruses. 2022; 14(6).
PMID: 35746741 PMC: 9228396. DOI: 10.3390/v14061270.
Yero A, Farnos O, Clain J, Zghidi-Abouzid O, Rabezanahary H, Racine G J Virol. 2022; 96(7):e0025522.
PMID: 35311550 PMC: 9006892. DOI: 10.1128/jvi.00255-22.
Shu W, Du F, Bai J, Yin L, Duan K, Li C Curr HIV Res. 2021; 20(1):91-99.
PMID: 34961450 PMC: 9127730. DOI: 10.2174/1570162X20666211227154558.
Andrieu J, Lu W Arch Virol. 2021; 166(5):1273-1282.
PMID: 33507389 PMC: 8036203. DOI: 10.1007/s00705-020-04935-6.
Recent Advances in Antigen-Specific Immunotherapies for the Treatment of Multiple Sclerosis.
Kammona O, Kiparissides C Brain Sci. 2020; 10(6).
PMID: 32486045 PMC: 7348736. DOI: 10.3390/brainsci10060333.